Advertisement

Acta Neuropathologica

, Volume 113, Issue 1, pp 13–21 | Cite as

Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles

  • Thomas G. BeachEmail author
  • Jeffrey R. Wilson
  • Lucia I. Sue
  • Amanda Newell
  • Marissa Poston
  • Raquel Cisneros
  • Yoga Pandya
  • Chera Esh
  • Donald J. Connor
  • Marwan Sabbagh
  • Douglas G. Walker
  • Alex E. Roher
Original Paper

Abstract

The role of intracranial atherosclerosis in Alzheimer’s disease (AD) has been a subject of debate since the first decade of the last century. The initial “vascular hypothesis” of AD was rejected after a series of mid-twentieth century gross anatomical postmortem studies that showed an inconstant relationship between intracranial atherosclerosis and senile dementia. These early studies did not utilize statistical methods, however, and the investigators did not appear to consider the possibility that intracranial atherosclerosis might have a probabilistic, rather than an absolute, effect on AD risk. Recent studies by three independent groups have found a significant statistical association between postmortem measures of circle of Willis atherosclerosis and AD. The present study was undertaken to further address the validity of this association in a large autopsy series, including cases diagnosed neuropathologically with vascular dementia (VaD) and non-AD dementias. Postmortem gross anatomical grading of circle of Willis atherosclerosis was performed in 397 subjects classified by neuropathological diagnosis, including 92 non-demented elderly controls, 215 with AD, 30 with VaD and 60 with non-AD dementias. Circle of Willis atherosclerosis was more severe in subjects with AD and VaD than in control subjects, while it was equivalent between control subjects and subjects with non-AD dementias. Increasing atherosclerotic grade increased the odds ratios (OR) for the diagnoses of both AD and VaD and also increased the ORs for both increased neuritic plaque density and higher Braak neurofibrillary tangle stage. The significance of these associations was retained after consideration of the effects of age, gender and the apolipoprotein E-ε4 allele. The results suggest that the statistical association between intracranial atherosclerosis and AD is not an artifact of diagnostic misclassification or of unequal distribution of the apolipoprotein E-ε4 allele.

Keywords

Alzheimer’s disease Atherosclerosis Neuropathology Circle of Willis Risk factor Apolipoprotein E 

Notes

Acknowledgments

This research was supported by grants from the National Institute of Health to Dr. A. Roher (RO1 AG19795), to Dr. T. Beach (R01 NS38674) and to the Arizona Alzheimer’s Disease Core Center (P30 AG19610-01), and also by the Arizona Department of Health Services (contract 211002, Arizona Alzheimer’s Research Consortium) and the Arizona Biomedical Research Commission (contract 0011, Arizona Parkinson’s Disease Center).

References

  1. 1.
    Almeida OP, Hulse GK, Lawrence D, Flicker L (2002) Smoking as a risk factor for Alzheimer’s disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 97:15–28PubMedCrossRefGoogle Scholar
  2. 2.
    Alzheimer A, Forstl H, Levy R (1991) On certain peculiar diseases of old age. Hist Psychiatry 2:71–101PubMedGoogle Scholar
  3. 3.
    Arab A (1954) Plaques seniles et arteriosclerose cerebrale. Absence de rapports de dependance entre les deux processus. Etude statistique. Rev Neurol 91:22–36PubMedGoogle Scholar
  4. 4.
    Beach TG (1987) The history of Alzheimer’s disease: three debates. J Hist Med Allied Sci 42:327–349PubMedGoogle Scholar
  5. 5.
    Beilby JP, Hunt CC, Palmer LJ, Chapman CM, Burley JP, McQuillan BM, Thompson PL, Hung J (2003) Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth carotid ultrasound disease assessment study (CUDAS). Stroke 34:869–874PubMedCrossRefGoogle Scholar
  6. 6.
    Boudreau DA, Scheer WD, Malcom GT, Mulvad G, Pedersen HS, Jul E (1999) Apolipoprotein E and atherosclerosis in Greenland Inuit. Atherosclerosis 145:207–219PubMedCrossRefGoogle Scholar
  7. 7.
    Braak H, Braak E (1991a) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216Google Scholar
  8. 8.
    Braak H, Braak E (1991b) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239–259CrossRefGoogle Scholar
  9. 9.
    Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19:253–262PubMedCrossRefGoogle Scholar
  10. 10.
    Cattin L, Fisicaro M, Tonizzo M, Valenti M, Danek GM, Fonda M, Da Col PG, Casagrande S, Pincetri E, Bovenzi M, Baralle F (1997) Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol 17:91–94PubMedGoogle Scholar
  11. 11.
    Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923PubMedCrossRefGoogle Scholar
  12. 12.
    Corsellis JAN (1976) Ageing and the dementias. In: Blackwood W, Corsellis JAN (eds) Greenfield’s neuropathology, p 796Google Scholar
  13. 13.
    de la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33:1152–1162CrossRefGoogle Scholar
  14. 14.
    Dickson DW (2005) Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol (Berl) 109:14–24CrossRefGoogle Scholar
  15. 15.
    Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC (2002) Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 33:1357–1361PubMedCrossRefGoogle Scholar
  16. 16.
    Fernandez-Miranda C, Aranda JL, Martin MA, Arenas J, Nunez V, Gomez dlC (2004) Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease. Int J Cardiol 94:209–212PubMedCrossRefGoogle Scholar
  17. 17.
    Fujishima M, Tsuchihashi T (1999) Hypertension and dementia. Clin Exp Hypertens 21:927–935PubMedGoogle Scholar
  18. 18.
    Fuller SC (1912) Alzheimer’s disease (senium praecox): the report of a case and review of published cases. J Nerv Ment Dis 39:440–536CrossRefGoogle Scholar
  19. 19.
    Grmek MD (1958) On ageing and old age: basic problems and historic aspects of gerontology and geriatrics. Mono Biol 5:69–74Google Scholar
  20. 20.
    Hachinski V (1974) Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 2:207–209PubMedCrossRefGoogle Scholar
  21. 21.
    Hachinski V, Munoz D (2000) Vascular factors in cognitive impairment—where are we now? Ann NY Acad Sci 903:1–5PubMedCrossRefGoogle Scholar
  22. 22.
    Hanon O, Luong V, Mourad JJ, Bortolotto LA, Jeunemaitre X, Girerd X (2001) Aging, carotid artery distensibility, and the Ser422Gly elastin gene polymorphism in humans. Hypertension 38:1185–1189PubMedGoogle Scholar
  23. 23.
    Herrmann W, Knapp JP (2002) Hyperhomocysteinemia: a new risk factor for degenerative diseases. Clin Lab 48:471–481PubMedGoogle Scholar
  24. 24.
    Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548PubMedGoogle Scholar
  25. 25.
    Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349:151–154PubMedCrossRefGoogle Scholar
  26. 26.
    Honig LS, Kukull W, Mayeux R (2005) Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology 64:494–500PubMedGoogle Scholar
  27. 27.
    Horejsi B, Spacil J, Ceska R, Vrablik M, Haas T, Horinek A (2000) The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness. Int Angiol 19:331–336PubMedGoogle Scholar
  28. 28.
    Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097PubMedGoogle Scholar
  29. 29.
    Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109:813–836PubMedCrossRefGoogle Scholar
  30. 30.
    Jellinger KA, Mitter-Ferstl E (2003) The impact of cerebrovascular lesions in Alzheimer disease—a comparative autopsy study. J Neurol 250:1050–1055PubMedCrossRefGoogle Scholar
  31. 31.
    Kahraman S, Kiykim AA, Altun B, Genctoy G, Arici M, Gulsun M, Erdem Y, Yasavul U, Turgan C, Caglar S (2004) Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function. Clin Transplant 18:288–294PubMedCrossRefGoogle Scholar
  32. 32.
    Kalback W, Esh C, Castano EM, Rahman A, Kokjohn T, Luehrs DC, Sue L, Cisneros R, Gerber F, Richardson C, Bohrmann B, Walker DG, Beach TG, Roher AE (2004) Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer’s disease. Neurol Res 26:525–539PubMedCrossRefGoogle Scholar
  33. 33.
    Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 322:1447–1451PubMedCrossRefGoogle Scholar
  34. 34.
    Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56:42–48PubMedGoogle Scholar
  35. 35.
    Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, Hatzigeorgiou G, Cariolou MA, Cokkinos DV (2002) Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease. Curr Med Res Opin 18:118–124PubMedCrossRefGoogle Scholar
  36. 36.
    Korczyn AD (2002) Homocysteine, stroke, and dementia. Stroke 33:2343–2344PubMedCrossRefGoogle Scholar
  37. 37.
    Kosunen O, Talasniemi S, Lehtovirta M, Heinonen O, Helisalmi S, Mannermaa A, Paljarvi L, Ryynanen M, Riekkinen PJ Sr, Soininen H (1995) Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 26:743–748PubMedGoogle Scholar
  38. 38.
    Lassen NA (1959) Cerebral blood flow and oxygen consumption in man. Physiol Rev 39:183–238PubMedGoogle Scholar
  39. 39.
    Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ (2000) Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49–55PubMedCrossRefGoogle Scholar
  40. 40.
    LauterH, Meyer JE (1968) Clinical and nosological concepts of senile dementia. In: Muller C, Ciompi L (eds) Senile dementia. Huber, Bern, pp 13–28Google Scholar
  41. 41.
    Lee AY, Jeong SH, Choi BH, Sohn EH, Chui H (2005) Pulse pressure correlates with leukoaraiosis in Alzheimer disease. Arch Gerontol Geriatr 42(2):157–166PubMedCrossRefGoogle Scholar
  42. 42.
    Lehtinen S, Lehtimaki T, Sisto T, Salenius JP, Nikkila M, Jokela H, Koivula T, Ebeling F, Ehnholm C (1995) Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 114:83–91PubMedCrossRefGoogle Scholar
  43. 43.
    Luthra K, Bharghav B, Chabbra S, Das N, Misra A, Agarwal DP, Pandey RM, Srivastava LM (2002) Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins. Mol Cell Biochem 232:97–102PubMedCrossRefGoogle Scholar
  44. 44.
    Maalikjy AN, Borroni B, Agosti C, Magoni M, Broli M, Pezzini A, Padovani A (2005) Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study. J Neurol 252:559–563CrossRefGoogle Scholar
  45. 45.
    Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease. Ann Neurol 34:752–754PubMedCrossRefGoogle Scholar
  46. 46.
    McGaffin CG (1910) An anatomical analysis of 70 cases of senile dementia. Am J Insan 65:649–656Google Scholar
  47. 47.
    McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33:2351–2356PubMedCrossRefGoogle Scholar
  48. 48.
    McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMedGoogle Scholar
  49. 49.
    Merchant C, Tang MX, Albert S, Manly J, Stern Y, Mayeux R (1999) The influence of smoking on the risk of Alzheimer’s disease. Neurology 52:1408–1412PubMedGoogle Scholar
  50. 50.
    Messier C (2003) Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol 38:941–946PubMedCrossRefGoogle Scholar
  51. 51.
    Miida T (1990) Apolipoprotein E phenotypes in patients with coronary artery disease. Tohoku J Exp Med 160:177–187PubMedGoogle Scholar
  52. 52.
    Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedGoogle Scholar
  53. 53.
    Mutrux S (1958) Contribution a l’etude histologique differentielle de la demence senile et de la maladie d’Alzheimer. Psychiatr Neurol, Basel 136:146–156CrossRefGoogle Scholar
  54. 54.
    Noetzli J (1895) Ueber dementia senilis. Mitth Klin Med Inst Schweitz 3:249–320Google Scholar
  55. 55.
    Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM (1998) Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet 351:1840–1843PubMedCrossRefGoogle Scholar
  56. 56.
    Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu–Asia Aging Study. Diabetes 51:1256–1262PubMedGoogle Scholar
  57. 57.
    Qiu C, Winblad B, Viitanen M, Fratiglioni L (2003) Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. Stroke 34:594–599PubMedCrossRefGoogle Scholar
  58. 58.
    Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG (2003) Circle of Willis Atherosclerosis is a risk factor for sporadic Alzheimer’s disease. Arterioscler Thromb Vasc Biol 23:2055–2062PubMedCrossRefGoogle Scholar
  59. 59.
    Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260PubMedCrossRefGoogle Scholar
  60. 60.
    Rothschild D (1937) The pathobiologic changes in senile psychosis and their psychobiologic significance. Am J Psychiatr 93:757Google Scholar
  61. 61.
    Rothschild D (1942) Neuropathologic changes in arteriosclerotic psychoses and their psychiatric significance. Arch Neurol Psychiatr 48:417–427Google Scholar
  62. 62.
    Ruitenberg A, den Heiker T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57:789–794PubMedCrossRefGoogle Scholar
  63. 63.
    Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, Hirata RD (2000) Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta 300:139–149PubMedCrossRefGoogle Scholar
  64. 64.
    Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43:1467–1472PubMedGoogle Scholar
  65. 65.
    Scaglione L, Bergerone S, Gambino R, Imazio M, Macchia G, Cravetto A, Gaschino G, Baralis G, Rosettani E, Pagano G, Cassader M (1999) Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction. Nutr Metab Cardiovasc Dis 9:118–124PubMedGoogle Scholar
  66. 66.
    Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu–Asia aging study. Ann Neurol 52:168–174PubMedCrossRefGoogle Scholar
  67. 67.
    Skoog I, Kalaria RN, Breteler MM (1999) Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13(Suppl 3):S106–S114PubMedCrossRefGoogle Scholar
  68. 68.
    Sourander P, Sjogren H (1970) The concept of Alzheimer’s disease and its clinical implications. In: Wolstenholme GEW, O’Connor M (eds) Alzheimer’s Disease and Related Conditions.J&A Churchill, London, pp 11–32Google Scholar
  69. 69.
    Southard EE (1910) Anatomical findings in senile dementia: a diagnostic study bearing especially on the group of cerebral atrophies. Am J Insan 66:571–577Google Scholar
  70. 70.
    Sparks DL, Martin TA, Gross DR, Hunsaker JC III (2000) Link between heart disease, cholesterol, and Alzheimer’s disease: a review. Microsc Res Tech 50:287–290PubMedCrossRefGoogle Scholar
  71. 71.
    Tabara Y, Kohara K, Nakura J, Miki T (2001) Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 46:278–284PubMedCrossRefGoogle Scholar
  72. 72.
    Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people. J Neurol Sci 7:331–356PubMedCrossRefGoogle Scholar
  73. 73.
    Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11:205–242PubMedCrossRefGoogle Scholar
  74. 74.
    Torack RM (1979) Adult dementia: history, biopsy, pathology. Neurosurgery 4:434–442PubMedGoogle Scholar
  75. 75.
    Traykov L, Rigaud AS, Baudic S, Smagghe A, Boller F, Forette F (2002) Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci 203–204:177–181PubMedCrossRefGoogle Scholar
  76. 76.
    Watanabe T, Miyazaki A, Katagiri T, Yamamoto H, Idei T, Iguchi T (2005) Relationship between serum insulin-like growth factor-1 levels and Alzheimer’s disease and vascular dementia. J Am Geriatr Soc 53:1748–1753PubMedCrossRefGoogle Scholar
  77. 77.
    Worm-Petersen J, Pakkenberg H (1968) Atherosclerosis of cerebral arteries, pathological and clinical correlations. J Gerontol 23:445–449PubMedGoogle Scholar
  78. 78.
    Yamamura T, Dong LM, Yamamoto A (1992) Apolipoprotein E polymorphism and coronary heart disease. Chin Med J (Engl) 105:738–741Google Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Thomas G. Beach
    • 1
    Email author
  • Jeffrey R. Wilson
    • 2
  • Lucia I. Sue
    • 1
  • Amanda Newell
    • 1
  • Marissa Poston
    • 1
  • Raquel Cisneros
    • 1
  • Yoga Pandya
    • 1
  • Chera Esh
    • 3
  • Donald J. Connor
    • 4
  • Marwan Sabbagh
    • 4
  • Douglas G. Walker
    • 5
  • Alex E. Roher
    • 3
  1. 1.W.H. Civin Laboratory for NeuropathologySun Health Research InstituteSun CityUSA
  2. 2.School of Health Management and PolicyArizona State UniversityTempeUSA
  3. 3.Napolean Longtine Center for Molecular Biology and GeneticsSun Health Research InstituteSun CityUSA
  4. 4.Cleo Roberts Center for Clinical ResearchSun Health Research InstituteSun CityUSA
  5. 5.Laboratory of NeuroinflammationSun Health Research InstituteSun CityUSA

Personalised recommendations